BioMedical Enterprises, a maker of nitinol orthopedic implants for treating deformities of the foot, ankle, hand and wrist, has been acquired by DePuy Orthopaedics, a unit of the DePuy Synthes Cos. of Johnson & Johnson. The purchase allows DePuy Synthes, which is focused on small bone fixation in trauma, to reinforce its product offerings for elective extremity procedures.
A regulatory filing disclosed that Hansen Medical has obtained $10 million in a funding round. The Mountain View, Calif.-based company develops flexible robotics technology for clinical uses, including the Magellan Robotic System designed to aid doctors during intravascular procedures.
Johnson & Johnson has finalized its purchase of Swiss orthopedic device maker Synthes for $19.7 billion in cash and company stock. Johnson & Johnson announced that it will merge Synthes with its DePuy unit to form the DePuy Synthes Cos. of Johnson & Johnson.
OrthoWorx, an initiative that seeks to expand the orthopedics industry in Indiana, has appointed David Floyd as CEO. Floyd in March resigned from his position as CEO of DePuy Orthopaedics, a Johnson & Johnson unit, amid the recall of the company's ASR hip replacement system.
Ashcroft Group Consulting Services, the law firm of former U.S. Attorney General John Ashcroft, is among five legal teams selected to monitor orthopedic manufacturers' compliance with a settlement concerning alleged payments to orthopedic surgeons to use and promote the companies' products. Ashcroft's firm is monitoring the compliance of Zimmer Holdings. Other orthopedic implant makers that have agreed to comply with the settlement deal include Biomet Orthopedics, DePuy Orthopaedics, Smith & Nephew plc and Stryker Corp.